OptiBiotix Health (FRA:OB3) EBIT : €-15.34 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is OptiBiotix Health EBIT?

OptiBiotix Health's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2023 was €-2.16 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was €-15.34 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. OptiBiotix Health's annualized ROC % for the quarter that ended in Jun. 2023 was -16.23%. OptiBiotix Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -908.94%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. OptiBiotix Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -82.31%.

OptiBiotix Health EBIT Historical Data

The historical data trend for OptiBiotix Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health EBIT Chart

OptiBiotix Health Annual Data

Trend

Jul10

Jul12

Nov14

Nov15

Nov16

Nov17

Nov18

Dec20

Dec21

Dec22

EBIT

Get a 7-Day Free Trial

1.91

-2.21

6.36

7.33

2.81

OptiBiotix Health Semi-Annual Data
	Jul12	Jan13	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EBIT	Get a 7-Day Free Trial															16.64	-9.49	16.20	-13.18	-2.16

Competitive Comparison of OptiBiotix Health's EBIT

For the Biotechnology subindustry, OptiBiotix Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OptiBiotix Health's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's EV-to-EBIT falls into.

OptiBiotix Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-15.34 Mil.

OptiBiotix Health (FRA:OB3) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

OptiBiotix Health's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

	ROC % (Q: Jun. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2022 )	+	Invested Capital (Q: Jun. 2023 ))	/ count )
=	-1.772 * ( 1 - 0.42% )	/	( (11.829	+	9.922)	/ 2 )
=	-1.7645576	/	10.8755
=	-16.23 %

where

	Invested Capital		(Q: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	13.278	-	0.239	-	( 1.21	-	max(0, 0.32	-	2.135	+	1.21	))
=	11.829

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	11.562	-	0.599	-	( 1.041	-	max(0, 0.599	-	2.149	+	1.041	))
=	9.922

Note: The Operating Income data used here is two times the semi-annual (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

OptiBiotix Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2022		Q: Jun. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-4.322	/	( ( (0 + max(0.442, 0))	+	(0 + max(0.509, 0)) )	/	2 )
=	-4.322	/	( ( 0.442	+	0.509 )	/	2 )
=	-4.322	/	0.4755
=	-908.94 %

where Working Capital is:

	Working Capital		(Q: Dec. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.436	+	0.205	+	0.121)	-	(0.239	+	0	+	0.081)
=	0.442

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.776	+	0.209	+	0.123)	-	(0.599	+	0	+	0)
=	0.509

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

OptiBiotix Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2023 )
	=	-15.341	/	18.638
	=	-82.31 %

OptiBiotix Health EBIT Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

OptiBiotix Health (FRA:OB3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (FRA:OB3) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

OPTI.GB:UK OPTI:UK

Address

Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG

Website

https://www.optibiotix.com

OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.

OptiBiotix Health (FRA:OB3) Headlines

No Headlines